Antrinkos Andrew Aristidou
About Antrinkos Andrew Aristidou
Data last updated:
Antrinkos Andrew Aristidou was a Cfo at Glaxosmithkline Pharmaceuticals Limited (2014–2017) and Director at Biddle Sawyer Limited (2014–2017). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glaxosmithkline Pharmaceuticals Limited L24239MH1924PLC001151 | Cfo | 01 Dec 2014 | 1924 | ₹3,895 Cr (FY 2025) | Active |
 Biddle Sawyer Limited U51900MH1948PLC006218 | Director | 01 Dec 2014 | 1948 | ₹54.40 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Antrinkos Andrew Aristidou
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antrinkos Andrew Aristidou
Antrinkos Andrew Aristidou was first appointed on 01 Dec 2014 as Cfo at Glaxosmithkline Pharmaceuticals Limited.
Antrinkos Andrew Aristidou held 2 earlier board appointments: Glaxosmithkline Pharmaceuticals Limited (Cfo, 01 Dec 2014 to 31 Dec 2017); Biddle Sawyer Limited (Director, 01 Dec 2014 to 31 Dec 2017).